← All Cbdmd, INC filings

Cbdmd, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

AMEX
YCBD
Cbdmd, INC
10-K/A: cbdMD Amends 10-K, Details Executive Pay & Governance
cbdMD, Inc. filed an amended annual report to include executive compensation, corporate governance, and related party transaction details previously omitted from its 2025 10-K.
AMEX
YCBD
Cbdmd, INC
10-K: cbdMD Navigates Regulatory Headwinds, Secures Capital
cbdMD, Inc. reports reduced operating losses and secures new capital through preferred stock and equity line, while facing significant regulatory challenges in the hemp-derived cannabinoid market.
AMEX
YCBD
Cbdmd, INC
10-K/A: cbdMD Files Amendment to 10-K to Include Omitted Information on Directors and Executive Compensation
cbdMD, Inc. filed an amendment to its annual report on Form 10-K to include information previously omitted regarding directors, executive officers, and executive compensation.
AMEX
YCBD
Cbdmd, INC
10-K: cbdMD, Inc. Reports Fiscal Year 2024 Results, Focuses on Cost Reduction and Strategic Growth
cbdMD, Inc. reports a reduced operating loss and improved adjusted EBITDA for fiscal year 2024, while navigating industry headwinds and focusing on strategic growth initiatives.
AMEX
YCBD
Cbdmd, INC
10-K/A: cbdMD, Inc. Files Amended 10-K Report Including Part III Information
cbdMD, Inc. has filed an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.